Research On The Improvement Of Financial Internal Control System Of G Company

With the rapid development of life science and technology,the huge market demand makes the emerging biomedical service outsourcing(CRO)enterprises develop and expand rapidly in recent years.Meanwhile,due to the fluctuating market environment and impact of COVID-19,enterprises are facing hitherto unknown risks.Benefiting from the industry dividend,G company developed and expanded rapidly.However,the management level cannot keep up with the development speed and a series of problems become more and more serious.The revenue growth slowly in recent years,and the lack of financial internal control system of reasonable and effective income and reimbursement process has become the bottleneck restricting the further development of G company,and the process improvement is imminent.Based on the latest internal control management theory and combined with the five elements of internal control,this thesis studies the expense reimbursement and income process of company G.Find the key points of existing process control,in order to reduce the defects of financial internal control in this link and improve the company’s financial internal control process.This research is of great significance for enriching and perfecting the internal control theory,improving enterprise benefits and maximizing enterprise value.Firstly,by summarizing a large number of documents and drawing lessons from COSO’s management thought,risk management theory and relevant principles of process reengineering,this thesis optimizes and improves the financial internal control management framework of G company from the aspects of expense reimbursement and income process.Secondly,by combing and analyzing the existing processes and key control points of G company,this thesis puts forward the problems of G company on the process system of income and expense reimbursement:lack of good internal control environment,lack of credit management links,imperfect internal control and supervision mechanism,ultra vires approval of the management,etc.On this basis,it puts forward suggestions and measures for process improvement,improves the revenue and price approval process,establishes customer credit management system,updates and formulates new financial reimbursement system norms,and actively implements relevant internal control system training for employees.Finally,the shortcomings and prospects of the research are put forward.This thesis only improves the income and expense reimbursement process of G company from the perspective of financial internal control,and does not cover all the contents of internal control.There are deficiencies in the integrity of internal control.In the future,more in-depth analysis and process improvement can be done,and more indicators and processes suitable for the company’s operation can be set from the perspective of internal control.From the perspective of financial internal control,this thesis improves the process of income and expense reimbursement of G company in biomedical cro industry.The research conclusion is not only conducive to the improvement of the internal control management system of G company,but also can provide reference for peer enterprises.There are innovations in the research perspective and practice object.